The Patient: The What, Why, and How of Medical Information The What, Why, and How of Medical Information In a recent Q1 Productions survey, patients and caregivers shared their thoughts about medical and disease information. The preferred vehicles of...
Insurers have begun moving back into counties where insurance plans had previously been “bare.” Following the exit of many payers from the Affordable Care Act, some insurance companies are taking the non-existent market as their chance to offer comprehensive...
A thirty-year old asthma treatment is being re-introduced as a medication for type-2 diabetes. The anti-inflammatory, Amlexanox, was originally created in Japan in the 1980s. After much testing, a team of researchers at the University of California San Diego have...
Podimetrics, a biotech company created during an MIT “hackathon” has unveiled its latest diabetes monitoring device. The device, the Podimetrics Remote Temperature Monitoring System, is a mat designed to indicate when foot ulcers may be forming. Foot ulcers in...
The Spanish biotech firm, Araclon, has contracted Ixico to conduct analysis results from it Alzheimer’s vaccine candidate. The vaccine, named ABvac40, is being tested in patients using imaging software to understand the drug’s impact on brain activity. The software...
